Lyphe Group and Boveda forge partnership for UK cannabis patients

By |2023-09-15T03:20:51+01:0015 September 2023|

UK medical cannabis company, Lyphe Group, has announced a new partnership to enhance how patients receive their cannabis prescriptions.  In what is thought to be an industry first, Lyphe Group’s dispensing pharmacy, Dispensary Green, has partnered with Boveda Inc, a global leader in two-way humidity control, [...]

Comments Off on Lyphe Group and Boveda forge partnership for UK cannabis patients

BBC documentary highlights ‘pot luck’ of access to cannabis on NHS

By |2023-09-15T03:20:37+01:0015 September 2023|

Approaching five years since medical cannabis was legalised in the UK, a new BBC documentary accuses the government of misleading the public over its availability on the NHS.  On 1 November, 2023 medical cannabis will have been legally available on prescription in the UK for five [...]

Comments Off on BBC documentary highlights ‘pot luck’ of access to cannabis on NHS

NIDA funds $3.69m study on role of genetics in response to THC

By |2023-09-15T03:20:23+01:0015 September 2023|

Researchers have received a $3.69 million grant from the National Institute on Drug Abuse (NIDA) to study how genetic differences influence behavioural and physiological responses to tetrahydrocannabinol (THC). Increased legalisation of medical and/or recreational cannabis and more favourable public perspectives has led to an increase in [...]

Comments Off on NIDA funds $3.69m study on role of genetics in response to THC

Lone Star Cannabis: What’s Holding Texas Back?

By |2023-09-15T03:20:01+01:0015 September 2023|

Adult-use cannabis has gained steam across the nation as more and more states jump on the legalization train. As of the writing of this article, 23 states have legalized adult-use while another 15 have allowed the sale of cannabis for medicinal purposes, for a total of [...]

Comments Off on Lone Star Cannabis: What’s Holding Texas Back?